Body Mass Index-Adjusted Body Weight Loss Grading Predicts Overall Survival in Esophageal Squamous Cell Carcinoma Patients

References

• Engel LS, Chow W-H, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404–1413. doi:10.1093/jnci/djg047
   PubMed Web of Science ®Google Scholar
• Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24(5):729–735. doi:10.1111/j.1440-1746.2009.05824.x
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–286. doi:10.5732/cjc.011.10390
   PubMed Web of Science ®Google Scholar
• Wang BY, Goan YG, Hsu PK, Hsu WH, Wu YC. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91(3):887–893. doi:10.1016/j.athoracsur.2010.11.011
   PubMed Web of Science ®Google Scholar
• Yuequan J, Shifeng C, Bing Z. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery. Ann Thorac Surg. 2010;90(3):908–913. doi:10.1016/j.athoracsur.2010.05.060
   PubMed Web of Science ®Google Scholar
• Zhang H, Liang H, Gao Y, Shang X, Gong L, Ma Z, Sun K, Tang P, Yu Z. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy. Sci Rep. 2016;6(1):38804. doi:10.1038/srep38804
   PubMed Web of Science ®Google Scholar
• DeWys W. Management of cancer cachexia. Semin Oncol. 1985;12(4):452–460.
   PubMed Web of Science ®Google Scholar
• Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003;22:235–239.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Supp 2):S51–S63. doi:10.1016/j.ejon.2005.09.007
   PubMedGoogle Scholar
• Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C. Prognostic factors in esophageal cancer treated with curative intent. Dig Liver Dis. 2018;50(10):991–996. doi:10.1016/j.dld.2018.08.002
   PubMedGoogle Scholar
• Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, Anderson LA, EUROCARE-4 Working Group. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505–512. doi:10.1016/j.canep.2012.07.009
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Q, Xu L, Chen Y, Wei Y, Zhou G. Factors predictive of prognosis after esophagectomy for squamous cell cancer. J Thorac Cardiovasc Surg. 2009;137(1):55–9. doi:10.1016/j.jtcvs.2008.05.024
   PubMed Web of Science ®Google Scholar
• Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–1146. doi:10.1111/jgh.13289
   PubMed Web of Science ®Google Scholar
• Pan Y-P, Hsu T-Y, Lin J-Y, Ho C-J, Kuan C-Y, Chou W-C, Lai C-H, Chang P-H, Yeh K-Y. Prognostic significance of low body mass index and betel-quid use in the 5-year survival rates of esophageal squamous cell carcinoma patients. Nutr Cancer. 2018;70(8):1315–1321. doi:10.1080/01635581.2019.1588983
   PubMed Web of Science ®Google Scholar
• Pan W, Sun Z, Xiang Y, Fang W. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies. Asia Pac J Clin Nutr. 2015;24(3):480–488. doi:10.6133/apjcn.2015.24.3.05
   PubMed Web of Science ®Google Scholar
• Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, Peto R, Huang Z, Chen Z. Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer. 2008;122(7):1604–1610. doi:10.1002/ijc.23198
   PubMed Web of Science ®Google Scholar
• Grotenhuis BA, Wijnhoven BPL, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJB. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg. 2010;34(11):2621–2627. doi:10.1007/s00268-010-0697-8
   PubMed Web of Science ®Google Scholar
• Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, Burney I, Valimohd A, Jafri W. Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol. 2004;15(1):118–122. doi:10.1093/annonc/mdh014
   PubMed Web of Science ®Google Scholar
• Liu B, Cheng B, Wang C, Chen P, Cheng Y. The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma. Sci Rep. 2018;8(1):10101. doi:10.1038/s41598-018-28268-2
   PubMed Web of Science ®Google Scholar
• Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271:693–700.
   PubMed Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Hayashi H, Takai K, Nakada S, et al. Prognostic importance of controlling nutritional status in patients undergoing curative thoracoscopic esophagectomy for esophageal cancer. Am J Ther. 2016;25:1–9.
   Web of Science ®Google Scholar
• Ji W, Zheng W, Li B, Cao C, Mao W. Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: A 10-year medical experience. Medicine. 2016;95(29):e4204. doi:10.1097/MD.0000000000004204
   PubMed Web of Science ®Google Scholar
• Pan H, Cai S, Ji J, Jiang Z, Liang H, Lin F, Liu X. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals. Nutr Cancer. 2013;65(1):62–70. doi:10.1080/01635581.2013.741752
   PubMed Web of Science ®Google Scholar
• Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, Uchida E. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):646–254. doi:10.1245/s10434-015-4869-5
   PubMed Web of Science ®Google Scholar
• Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag. 2014;10:1–7.
   PubMed Web of Science ®Google Scholar
• Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, Strasser F, Thoresen L, Jagoe RT, Chasen M, et al. Diagnostic criteria for the classification of cancer-associated weight loss. JCO. 2015;33(1):90–99. doi:10.1200/JCO.2014.56.1894
   PubMed Web of Science ®Google Scholar
• Sun P, Zhang F, Chen C, An X, Li YH, et al. Comparison of the prognostic values of various nutritional parameters in patients with esophageal squamous cell carcinoma from Southern China. J Thorac Dis. 2013;5:484–491.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• McLaren PJ, Bronson NW, Hart KD, Vaccaro GM, Gatter KM, Thomas CR, Hunter JG, Dolan JP. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios can predict treatment response to neoadjuvant therapy in esophageal cancer. J Gastrointest Surg. 2017;21(4):607–613. doi:10.1007/s11605-016-3351-4
   PubMed Web of Science ®Google Scholar
• Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–2396. doi:10.1016/S0140-6736(17)31462-9
   PubMed Web of Science ®Google Scholar
• Backemar L, Lagergren P, Johar A, Lagergren J. Impact of co-morbidity on mortality after oesophageal cancer surgery. Br J Surg. 2015;102(9):1097–1105. doi:10.1002/bjs.9854
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95(7):1434–1443. doi:10.1002/cncr.10868
   PubMed Web of Science ®Google Scholar
• van der Schaaf MK, Tilanus HW, van Lanschot JJB, Johar AM, Lagergren P, Lagergren J, Wijnhoven BPL. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147(1):490–495. doi:10.1016/j.jtcvs.2013.07.072
   PubMed Web of Science ®Google Scholar
• Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–198. doi:10.1038/nrclinonc.2015.200
   PubMed Web of Science ®Google Scholar
• Dijksterhuis WPM, Pruijt MJ, van der Woude SO, Klaassen R, Kurk SA, van Oijen MGH, van Laarhoven HWM. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle. 2019;10(1):199–206. doi:10.1002/jcsm.12371
   PubMed Web of Science ®Google Scholar
• Anandavadivelan P, Brismar TB, Nilsson M, Johar AM, Martin L. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr. 2016;35(3):724–730. doi:10.1016/j.clnu.2015.05.011
   PubMed Web of Science ®Google Scholar
• Lin M-Y, Chen M-C, Wu I-C, Wu D-C, Cheng Y-J, Wu C-C, Chai C-Y, Lee J-M, Wu M-T. Areca users in combination with tobacco and alcohol use are associated with younger age of diagnosed esophageal cancer in Taiwanese men. PLoS One. 2011;6(10):e25347. doi:10.1371/journal.pone.0025347
   PubMed Web of Science ®Google Scholar
• Poziomyck AK, Fruchtenicht AVG, Kabke GB, Volkweis BS, Antoniazzi JL, Moreira LF. Reliability of nutritional assessment in patients with gastrointestinal tumors. Rev Col Bras Cir. 2016;43(3):189–197. doi:10.1590/0100-69912016003006
   PubMedGoogle Scholar
• Wu I-C, Wu C-C, Lu C-Y, Hsu W-H, Wu M-C, Lee J-Y, Chou S-H, Lee J-M, Chou Y-P, Wu D-C, et al. Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma. PLoS One. 2013;8(2):e55834. doi:10.1371/journal.pone.0055834
   PubMed Web of Science ®Google Scholar
• Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, et al. Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. WJG. 2010;16(39):4958–4967. doi:10.3748/wjg.v16.i39.4958
   PubMed Web of Science ®Google Scholar